Age is an important factor when treating chronic HCV infection. The prevalence of anti-HCV seropositivity tends to be higher in the elderly than in younger individuals. Aging influence the progression of liver fibrosis and the development of HCC in older people. As life expectancy continues to rise, elderly adults represent a rapidly growing proportion of the population.
Please login to comment on this article